DE1443619A1 - Verfahren zur Herstellung neuer Methyloesterne - Google Patents

Verfahren zur Herstellung neuer Methyloesterne

Info

Publication number
DE1443619A1
DE1443619A1 DE19631443619 DE1443619A DE1443619A1 DE 1443619 A1 DE1443619 A1 DE 1443619A1 DE 19631443619 DE19631443619 DE 19631443619 DE 1443619 A DE1443619 A DE 1443619A DE 1443619 A1 DE1443619 A1 DE 1443619A1
Authority
DE
Germany
Prior art keywords
compound
methyl
oxo
aliphatic hydrocarbon
ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19631443619
Other languages
German (de)
English (en)
Inventor
Wettstein Dr Albert
Anner Dr Georg
Wieland Dr Peter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1377562A external-priority patent/CH451930A/de
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE1443619A1 publication Critical patent/DE1443619A1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J11/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE19631443619 1962-11-23 1963-11-16 Verfahren zur Herstellung neuer Methyloesterne Pending DE1443619A1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1377562A CH451930A (de) 1962-11-23 1962-11-23 Verfahren zur Herstellung neuer Methylöstrene
CH172663 1963-02-12
CH695663 1963-06-04
CH792363 1963-06-26

Publications (1)

Publication Number Publication Date
DE1443619A1 true DE1443619A1 (de) 1969-10-23

Family

ID=27428267

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19631443619 Pending DE1443619A1 (de) 1962-11-23 1963-11-16 Verfahren zur Herstellung neuer Methyloesterne

Country Status (5)

Country Link
AT (1) AT271744B (da)
DE (1) DE1443619A1 (da)
DK (1) DK109866C (da)
GB (1) GB1012493A (da)
SE (1) SE320662B (da)

Also Published As

Publication number Publication date
GB1012493A (en) 1965-12-08
DK109866C (da) 1968-07-22
AT271744B (de) 1969-06-10
SE320662B (da) 1970-02-16

Similar Documents

Publication Publication Date Title
DE1443681C3 (de) 7 Methyl östron und sein 3 Methyl ather, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE1618980B2 (de) In 17-stellung substituierte 11, 13beta-dialkylgon-4-en-3,17beta-diole und deren ester
DE1568308A1 (de) Verfahren zur Herstellung von delta4,9,11-Trienen der 19-Nor-androstanreihe
DE1443619A1 (de) Verfahren zur Herstellung neuer Methyloesterne
DE1947221A1 (de) 3-Aza-19-hydroxy-3,19-cyclo-A-homosteroide und ein Verfahren zu deren Herstellung
DE1807585C3 (de) 14,15beta-Epoxycardenolide, Verfahren zu deren Herstellung und diese enthaltende Mittel
CH522622A (de) Verfahren zur Herstellung eines neuen 6a-Methyl-19-nor-progesterons
DE1443619B (de) In 3-Stellung unsubstituierte 7 alpha-Methyl-4-östtene und Verfahren xu deren Herstellung
DE2449327C2 (de) 7 α-Hydroxy-östradiole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2007415C (de) 7alpha Methyl Oestratriol
AT274258B (de) Verfahren zur Herstellung von neuen 7α-Methyl-Δ<4,9,11>-19-nor-androstatrienen
DE1568308C3 (de) 10.09.65 Schweiz 12624-65 Verfahren zur Herstellung von Delta hoch 4,9,11-Trienen der 19-Norandrostanreihe, 17-oxygenierte 3-Oxo-7 alpha-methyl-Delta hoch 4,9,11-19 norandrostatriene und diese enthaltende pharmazeutische Präparate sowie 3-Oxo-7 alpha -methyl-Delta hoch 5 (10), 9 (11) -19-norandrostadiene
DE2651364A1 (de) Neue d-homosteroide
DE1618980C3 (de) In 17-Stellung substituierte 11, 13beta-Dialkylgon-4-en-3,17beta-diole und deren Ester
DE1593225C3 (de) Reine alpha- und beta-anomere, optisch aktive 3-(2'-Tetrahydropyranyloxy)-Derivate von Steroid-Östrogenen sowie Verfahren zu deren Herstellung
AT253704B (de) Verfahren zur Herstellung des neuen 7α-Methyl-16α-hydroxy-östrons und seines 3, 16-Diacetates
AT233177B (de) Verfahren zur Herstellung des neuen 6α-Methyl-17 α-hydroxyprogesterons und seiner Ester
DE2031237A1 (de) Verfahren zur Herstellung von neuen 5 beta, 19 (Epoxyathanoimino) steroiden
DE1105412B (de) Verfahren zur Herstellung von ?-3-Keto-6ª‡-methylsteroiden der Androstan- und Pregnanreihe
DE2160522A1 (de) Verfahren zur Herstellung von 14 beta, 18- und 5 beta, 19-(Epoxyäthanoimino)steroiden
DE2052166A1 (de) Verfahren zur Herstellung von 14 beta, 18 (Epoxyathanoimino) steroiden
DE2334829A1 (de) Cis-prostaglandinartige verbindungen und verfahren zu ihrer herstellung
CH642088A5 (de) C-homo-oestratriene.
CH537918A (de) Verfahren zur Herstellung neuer 3-Hydroxy-4-oxo-19-nor-A-homo-steroid-1(10),2,4a-trienen
DE1518658A1 (de) Neue 5,10-Seco-steroide

Legal Events

Date Code Title Description
SH Request for examination between 03.10.1968 and 22.04.1971